Annual and Special Meeting of Shareholders @ 1:00 PM MTJune 22, 2021
PBA à Noon Presentation with Resverlogix Corp.May 12, 2021
Corporate Update Webcast and Conference CallFebruary 4, 2021
2020 Annual and Special Meeting of ShareholdersDecember 22, 2020
2020 Virtual AHA Scientific SessionsNovember 13, 2020
ASN Kidney Week Reimagined 2020October 24, 2020
Global Chinese Financial Forum ("GCFF") Virtual Conference 2020 - Investing in InnovationSeptember 10, 2020
2020 Virtual Epigenetic Therapeutic Target SummitJuly 28, 2020
Corporate Update Conference Call & WebcastJune 10, 2020
ERA-EDTA 2020 Virtual Congress PresentationJune 9, 2020
BETonMACE Cognitive Assessment Results Webcast and Conference CallDecember 6, 2019
Detailed Preliminary BETonMACE Results Conference Call & WebcastNovember 18, 2019
Annual and Special Meeting of ShareholdersOctober 31, 2019
2019 ESC Symposium Lectures & VideosAugust 31, 2019
2019 ERA-EDTA Congress Symposium Lectures & VideosJune 15, 2019
Cognitive Evaluation of Treatment Effects of the Bromodomain Inhibitor Apabetalone - Dr. Jeffrey Cummings, MD, ScD - PDF March 30, 2019
2018 Annual & Special Meeting For Shareholders Presentation PDF September 12, 2018
